GlassScriptPhysician profile
Lillian Hwee
NPI 1750325312
$1,790.28
in general payments reported to CMS, 2019-2025
22 companies · $523 in 2025
The $523 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $186 · 2022: $16.40 · 2023: $438 · 2024: $387 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,347.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $348.44 | 2020-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $278.78 | 2019-2025 | |
| Lilly USA, LLC | $190.54 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $124.51 | 2019-2025 | Shingrix, Arexvy |
| Astellas Pharma US INC | $103.40 | 2023-2025 | Veozah, Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $103.36 | 2024-2025 | Airsupra, Farxiga |
| Pfizer INC. | $102.32 | 2023-2025 | |
| Exact Sciences Corporation | $77.99 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $69.46 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Amgen INC. | $58.42 | 2023-2025 | Evenity, Prolia, Otezla |
| Sanofi-Aventis U.S. LLC | $43.95 | 2020-2022 | |
| Dynavax Technologies Corporation | $40.77 | 2023 | Heplisav-B |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.90 | 2024-2025 | Xifaxan |
| Amarin Pharma, INC. | $28.89 | 2019 | |
| Indivior INC. | $27.38 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $27.00 | 2024-2025 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $25.73 | 2020-2023 | Seglentis, Livalo |
| Sanofi Pasteur INC. | $25.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.03 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $21.82 | 2025 | Rexulti |
| Inspire Medical Systems, INC. | $19.84 | 2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $14.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Hwee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.